Overall rank by patents
#25,681
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 8 technology areas, active 2016–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H04N (PICTORIAL COMMUNICATION, e.g. TELEVISION).
The verdict
Amimon holds 10 US patents across 8 technology areas, rank #25,681 of 50,000 tracked assignees.
Amimon Ltd. has been granted 10 US utility patents between 2016 and 2022, placing Amimon Ltd. at rank #25,681 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.3 claims per patent with primary concentration in H04N (PICTORIAL COMMUNICATION, e.g. TELEVISION). As a Foreign Corporation, Amimon Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Amimon sits between American Eagle Instruments, Llc (10 patents, rank #25,677) and Andro Computational Solutions, Llc (10 patents, rank #25,685) - the closest US assignees by grant volume. The composite Innovation Score of 32.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 2 in the 2015–2019 window, a +300% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Amimon Ltd.'s 16.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Amimon Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
AMERICAN EAGLE INSTRUMENTS, LLC
10 patents
AMERICAN MEDICAL CORPORATION
10 patents
AMETHYSTUM STORAGE TECHNOLOGY CO., LTD.
10 patents
AMF AUTOMATION TECHNOLOGIES, LLC
10 patents
AMPHENOL-AIR LB
10 patents
AMQ Solutions, LLC
10 patents
AMS-OSRAM AG
10 patents
ANDRO COMPUTATIONAL SOLUTIONS, LLC
10 patents
AMIMON LTD.
10 patents
What this shows Amimon holds 10 patents at rank #25,681, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Amimon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
32 Top 60% higher than 40% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 10.0% |
| 2017 | 1 | 10.0% |
| 2020 | 3 | 30.0% |
| 2021 | 2 | 20.0% |
| 2022 | 3 | 30.0% |
Top 8 of 8 technology areas
Overall rank by patents
#25,681
Across all tracked assignees
32.1 out of 100
How to use this portfolio
Amimon's 10 grants land it in the top 60% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.